These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 52868)

  • 1. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
    Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
    Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urina urokinase and blood fibrinolytic activity in w experimental zinc poisoning].
    Guja A
    Patol Pol; 1977; 28(2):201-8. PubMed ID: 887291
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary fibrinolytic enzyme activity in systemic diseases and chronic glomerulonephritis].
    Palienko IA; Belitskaia GA
    Vrach Delo; 1988 Feb; (2):71-3. PubMed ID: 3381527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
    Bachmann HJ; Tacke E; Haupt H
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
    Chohan IS; Singh I; Vermylen J; Verstraete M
    Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of the fibrinolytic activity of urine in certain kidney diseases].
    Karastanev I; Atanasov K
    Urol Nefrol (Mosk); 1976; (3):19-21. PubMed ID: 973260
    [No Abstract]   [Full Text] [Related]  

  • 8. Deficient urinary fibrinolysis in renal stone disease.
    Charlton CA; Osmond C
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1239-40. PubMed ID: 3085794
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urine fibrinolytic activity as an indicator of kidney damage in uric acid metabolic imbalance].
    Shcherbak AV; Balkarov IM; Kozlovskaia LV; Podorol'skaia LV; Gindis AA
    Ter Arkh; 2001; 73(6):34-7. PubMed ID: 11521518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the transfusions of autologous and allogeneic blood in patients with kidney and urinary tract diseases].
    Dutkevich IG; Golovin GV; Pytel' IuA; Tsomyk VG; Naskhletashvili VM
    Vestn Khir Im I I Grek; 1985 Dec; 135(12):101-3. PubMed ID: 2421475
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
    Marder VJ; Donahoe JF; Bell WR; Cranley JJ; Kwaan HC; Sashara AA; Barlow GH
    J Lab Clin Med; 1978 Nov; 92(5):721-9. PubMed ID: 712206
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H; Shibata M
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of orthostatic changes on urokinase excretion.
    Wilcox GM; Hial V; Horwitz D; Pisano JJ; Keiser HR
    Thromb Haemost; 1978 Feb; 39(1):69-73. PubMed ID: 580506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue plasminogen activator, its inhibitor and other parameters of fibrinolysis in blood of patients operated for mild hypertrophy of the prostate].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F; Cwiklińska-Jurkowska M
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1096-7. PubMed ID: 1284828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Product E, urokinase and uropepsinogen in the urine of diabetic children].
    Symonides-Lawecka A; Galczak W; Olech K; Wysocki M
    Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assay method for urinary urokinase using synthetic fluorogenic substrate (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1979 Mar; 27(3):218-22. PubMed ID: 439470
    [No Abstract]   [Full Text] [Related]  

  • 18. Do stone formers have lower urinary fibrinolytic activity than controls?
    Margetts BM; Barker DJ; Kavanagh JP; Blacklock NJ
    Br J Urol; 1990 Dec; 66(6):581-4. PubMed ID: 2265328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on unexplained renal hematuria. 1. Clinical studies of peripheral blood examination and fibrinolytic enzyme systems in patients with various types of renal hematuria (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):42-59. PubMed ID: 7024604
    [No Abstract]   [Full Text] [Related]  

  • 20. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.